Rivian drops as Q1 results highlight regulatory-credit drop, ongoing heavy cash burn
Rivian shares are sliding after the company reported Q1 2026 results on April 30, 2026, as investors focused on weaker profitability drivers despite continued gross profit. Automotive segment gross profit swung to a $62 million loss, largely tied to a $100 million drop in regulatory credit sales and lower production volumes.
1. What’s moving the stock
Rivian is lower in Friday trading (May 1, 2026) after its first-quarter 2026 earnings release on April 30, 2026 shifted attention back to near-term profitability headwinds and ongoing losses. While the company posted consolidated gross profit of $119 million, investors appeared to zero in on the automotive segment’s profitability pressure and the still-large adjusted EBITDA loss, tempering enthusiasm around the longer-term R2 ramp.
2. Key earnings details investors are reacting to
In the quarter, Rivian reported roughly $1.38 billion of revenue and an adjusted EBITDA loss of $472 million. The company’s automotive segment gross profit moved to a $(62) million loss versus $92 million of gross profit a year earlier, with the change driven primarily by a $100 million decrease in automotive regulatory credit sales and lower production volumes, which increased depreciation and stock-based compensation expense. Those line items are important because regulatory credits can be a meaningful, higher-margin contributor that can mask underlying manufacturing economics when strong—and the quarter showed that tailwind fading.
3. Guidance and the R2 ramp in focus
Rivian reiterated full-year 2026 delivery guidance of 62,000 to 67,000 vehicles and kept its 2026 adjusted EBITDA loss outlook at roughly $(2.1) billion to $(1.8) billion. The market’s read-through: even with the company preparing to scale R2, management is signaling another year of sizable losses as it invests in the launch and broader product roadmap, leaving the stock sensitive to any sign that margins or volumes could fall short during the ramp.
4. What to watch next
Near-term trading is likely to hinge on (1) evidence that R2 scaling improves unit economics versus R1, (2) whether regulatory-credit revenue stabilizes or remains a drag, and (3) any changes to delivery cadence versus guidance as the year progresses. Investors will also watch cash burn and liquidity metrics closely given the magnitude of the EBITDA loss and continued investment cycle.